Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Circulating tumor cell (CTC) characterization in metastatic breast cancer An important part of cancer progression is when the primary tumor starts to release tumor cells into the blood circulation. This is the first step towards metastatic disease and is thus of immense importance for disease development. It is well known that the number of cancer cells that can be found in the circulation (circulating tumor cells=CTCs) is of importance for patient prognosis. We have a method called CellSearch® (Janssen Diagnostics) that can be used to draw out CTCs from blood samples and enumerate CTCs using immunofluorescence. This method is used in a number of clinical studies here in Lund today and it is the most established method to study CTCs worldwide. In a previous study we have found that presence of CTCs that form clusters in the blood of patients with metastatic breast cancer is a significant sign of bad prognosis. The same is true for CTCs with apoptotic features (i.e. dying cancer cells in the blood). Both of these characteristics were only important when found at time-points when the patients had started their therapy. The aim of the present study is to continue with morphologic characterization of CTCs in patients with metastatic breast cancer. CTC size, shape, cytokeratin staining intensity and nuclear-tocytoplasmic ratio will be investigated in relation to prognosis, metastatic site, and breast cancer subtype. We hypothesize that small, round CTCs are more aggressive and might represent a more cancer stem cell like phenotype. Methods: Serial samples from patients with metastatic breast cancer will be investigated and the student will work with data from the ongoing CTC-MBC study (ethical permission EPN 2010/135). Blood samples have been drawn at baseline, 1-3 and 6 months of treatment and will be evaluated for CTC size, shape, nuclear-to-cytoplasmic ratio and staining intensity using the public domain JAVAbased image processing program ImageJ. Png formatted images from the CTC gallery will be used for the measurements and the perimeter, cross sectional area, longest and shortest diameter, circularity (how much the cell shape differ from a perfect circle) and intensity for all CTC and their corresponding nuclei. In a pilot study, CTCs and their corresponding nuclei have been measured in the baseline sample for each of 39 patients with ≥5 detected CTCs. Supervisors: Kristina Aaltonen (PhD) och Sara Jansson (MD, PhD-student)